JWCTF   $0.3592  -9.68% Market Closed

JW CAYMAN THERAPEUTICS CO
Total Cash 869.03M
totalCashPerShare 2.15
EBITDA -427.40M
Total Debt 380.53M
quickRatio 2.724
currentRatio 2.92
Total Revenue 172.93M
debtToEquity 25.678
Revenue/Share 0.419
ROA -0.1355
ROE -0.34665
grossProfits
freeCashflow -234.75M
operatingCashflow -348.59M
earningsGrowth
revenueGrowth -0.011
grossMargins 0.50396
ebitdaMargins -2.47149
operatingMargins -2.77043
profitMargins 0.0
enterpriseValue -385.42M
forwardPE
floatShares 306.28M
sharesOutstanding 415.07M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.24%
heldPercentInstitutions 0.01%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 3.666
Price To Book help_outline 0.07
earningsQuarterlyGrowth
netIncomeToCommon -627.85M
trailingEps -0.21%
forwardEps
enterpriseToEbitda 0.90
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 9
lastUpdated Nov. 7, 2024, 1:21 p.m.